Altheos Names Barbara Wirostko, M.D., Chief Medical Officer

News from Business Wire ms kathy, This press release was issued via BusinessWire.com. Go to www.BusinessWire.com for additional news - registration is free and quick! September 30, 2010 08:00 AM Eastern Daylight Time Altheos Names Barbara Wirostko, M.D., Chief Medical Officer SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Altheos, Inc., a biopharmaceutical company focused on next generation treatments for glaucoma and ocular hypertension, announced today that Barbara Wirostko, M.D., has been appointed Chief Medical Officer. Dr. Wirostko is a board certified ophthalmologist with glaucoma subspecialty training. Prior to joining Altheos, she was senior medical director and the glaucoma medical team lead at Pfizer where she was responsible for pipeline strategy in glaucoma, overseeing the pediatric development program and Global Medical Affairs Programs for the Xalabrands franchise. Prior to joining Pfizer, she was chief ophthalmologist specializing in glaucoma at the Huntington Medical Group PC in Huntington, NY. During her 10 years in practice, she was a clinical ... Read the full news release on BusinessWire.com Business Wire features breaking news from leading companies and organizations worldwide. We invite you to set up your free news profile personalized to your interests. Register now at www.BusinessWire.com.